Prostate cancer: On the road of progress

doi:10.1016/j.ajur.2019.01.002

Asian Journal of Urology, 2019, 6 (2): 123-124 doi: 10.1016/j.ajur.2019.01.002

Editorial

Current Issue | Archive | Adv Search

Prostate cancer: On the road of progress

Michel Bolla¹(

),René-Olivier Mirimanoff²(

)

1. Radiation Oncology, Grenoble Alpes University, Grenoble, France；
2. Radiation Oncology, University Hospital (CHUV), Lausanne, Switzerland

Abstract
Related Citation (0)

[1]	J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, H. Comber , et al.Cancer incidence Cancer incidence and mortality patterns in Europe : estimates for 40 countries in 2012. Eur J Cancer, 49(2013), pp. 1374-1403.
[2]	W. Chen, R. Zheng, H. Zeng, S. Zhang.The updated incidences and mortalities of major cancer in China, 2011. Chin J Cancer, 34(2015), pp. 502-507.
[3]	B.F. Hankey, E.J. Feuer, L.X. Clegg, R.B. Hayes, J.M. Legler, P.C. Prorok , et al.Cancer surveillance series : interpreting trends in prostate cancer-part I : evidence of the effects of screening in recent prostate incidence.J Natl Cancer Inst, 91(1999), pp. 1017-1024.
[4]	Mottet N, Bellmunt J , Briers and members of the EAU-ESTRO-ESUR-SIOG. Guidelines panel on Prostate Cancer. [accessed 26 December 2018 Briers and members of the EAU-ESTRO-ESUR-SIOG. Guidelines panel on Prostate Cancer. [accessed 26 December 2018].http://uroweb.org/guideline/prostate-cancer/ .
[5]	M. Bolla , H. van Poppel.Management of prostate cancer. A multidisciplinary approach.( 2nd ed.), Springer, Switzerland(2017), pp. 1-141.
[6]	J.L. Descotes.Diagnosis of prostate cancer.Asian J Urol, 6(2019), pp. 129-136.
[7]	O. Rouvière ,P.C. Moldovan.The current role of prostate multiparametric magnetic resonance imaging.source>Asian J Urol, 6(2019), pp. 137-145.
[8]	L. Klotz.Contemporary approach to active surveillance for favorable risk prostate cancer.Asian J Urol, 6(2019), pp. 146-152.
[9]	J.J. Tosoian, B.J. Trock, P. Landis, Z. Feng, J.I. Epstein, A.W. Partin , et al.Active surveillance program for prostatic cancer : an update of the John Hopkins experience.J Clin Oncol, 29(2011), pp. 2185-2190. doi: 10.1590/S1677-55382011000200021 pmid: 21464416
[10]	H. Van Poppel, W. Everaerts, L. Tosco , S. Joniau.Open and robotic radical prostatectomy.Asian J Urol, 6(2019), pp. 125-128.
[11]	M. Bolla, A. Henry, M. Mason , T. Wiegel. The role of radiotherapy in locally advanced prostate cancer.Asian J Urol, 6(2019), pp. 153-161 doi: 10.1016/j.radonc.2006.03.011 pmid: 16631267
[12]	G. Gravis.Systemic treatment for metastatic prostate cancer.Asian J Urol, 6(2019), pp. 162-168.
[13]	F.C. Hamdy, J.L. Donovan, J.A. Lane, M. Mason, C. Metcalfe, P. Holding , et al.10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer.N Engl J Med, 375(2016), pp. 1415-1424.
[14]	J.I. Epstein, L. Egevad, M.B. Amin, B. Delahunt, J.R. Srigley, P.A. Humphrey , et al.TheThe 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma : definition of grading patterns and proposal of a new grading system. Am J Surg Pathol, 40(2016), pp. 244-252